Genfleet Therapeutics (Shanghai), Inc. Class H (HK:2595)
:2595
2595 Stock Chart & Stats
HK$28.10
--
Market closed
HK$28.10
--
Day’s Range― - ―
52-Week RangeHK$19.60 - HK$50.20
Previous CloseN/A
VolumeN/A
Average Volume (3M)3.12M
Market Cap
HK$10.31B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.08
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding338,029,020
10 Day Avg. Volume1,088,501
30 Day Avg. Volume3,122,091
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$51.00Price Target Upside81.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Genfleet Therapeutics (Shanghai), Inc. Class H News
2595 FAQ
What was Genfleet Therapeutics (Shanghai), Inc. Class H’s price range in the past 12 months?
Genfleet Therapeutics (Shanghai), Inc. Class H lowest stock price was HK$19.60 and its highest was HK$50.20 in the past 12 months.
What is Genfleet Therapeutics (Shanghai), Inc. Class H’s market cap?
Genfleet Therapeutics (Shanghai), Inc. Class H’s market cap is HK$10.31B.
When is Genfleet Therapeutics (Shanghai), Inc. Class H’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Genfleet Therapeutics (Shanghai), Inc. Class H’s earnings last quarter?
Currently, no data Available
Is Genfleet Therapeutics (Shanghai), Inc. Class H overvalued?
According to Wall Street analysts Genfleet Therapeutics (Shanghai), Inc. Class H’s price is currently Undervalued.
Does Genfleet Therapeutics (Shanghai), Inc. Class H pay dividends?
Genfleet Therapeutics (Shanghai), Inc. Class H does not currently pay dividends.
What is Genfleet Therapeutics (Shanghai), Inc. Class H’s EPS estimate?
Genfleet Therapeutics (Shanghai), Inc. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genfleet Therapeutics (Shanghai), Inc. Class H have?
Genfleet Therapeutics (Shanghai), Inc. Class H has 338,029,020 shares outstanding.
What happened to Genfleet Therapeutics (Shanghai), Inc. Class H’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Genfleet Therapeutics (Shanghai), Inc. Class H?
Currently, no hedge funds are holding shares in HK:2595
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Genfleet Therapeutics (Shanghai), Inc. Class H Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$51.00 (81.49% Upside)
HK$51.00 (81.49% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-2.45%
Trailing 12-Months
2595 Stock 12 Month Forecast
Average Price Target
HK$51.00
▲(81.49% Upside)
Technical Analysis
Antengene Corporation Limited
―
Kintor Pharmaceutical Ltd
―
CANbridge Pharmaceuticals Inc.
―
Sirnaomics Ltd.
―
Transcenta Holding Limited
―
Options Prices
Currently, No data available
---